Impact of hyperglycemic control on left ventricular myocardium: A molecular and cellular basic study in a diabetic rat model

International Heart Journal

Volumn 50, Issue 2, 2009, Pages 191-206

  Sung, Pei Hsun ^a   Sun, Cheuk Kwan ^a   Ko, Sheung Fat ^a   Chang, Li Teh ^c   Sheu, Jiunn Jye ^a   Lee, Fan Yen ^a   Wu, Chiung Jen ^b   Chua, Sarah ^b   Yip, Hon Kan ^b  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c MEIHO UNIVERSITY   (Taiwan)

Author keywords

Hyperglycemia; Inflammation; Left ventricular dysfunction

Indexed keywords

ALPHA ACTIN; CONNEXIN 43; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; GELATINASE B; HEMOGLOBIN A1C; INSULIN ZINC SUSPENSION; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEIN KINASE C EPSILON; REACTIVE OXYGEN METABOLITE; STREPTOZOCIN; ANTIDIABETIC AGENT; HEMOGLOBIN A; INSULIN; MESSENGER RNA; NOS3 PROTEIN, RAT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1, RAT; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA COACTIVATOR-1, RAT; RNA BINDING PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BODY WEIGHT; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DIABETES CONTROL; DIABETES MELLITUS; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MITOCHONDRION; HEART WEIGHT; HYPERGLYCEMIA; IMMUNOFLUORESCENCE; INFLAMMATION; MALE; MOLECULAR DYNAMICS; MORNING DOSAGE; NICK END LABELING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; STREPTOZOCIN DIABETES; ANIMAL; BIOSYNTHESIS; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; GENETICS; HEART MUSCLE; HEART VENTRICLE; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; APOPTOSIS; CONNEXIN 43; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; ENDOTHELIN-1; HEART VENTRICLES; HEMOGLOBIN A; HYPOGLYCEMIC AGENTS; INSULIN; MATRIX METALLOPROTEINASE 9; MYOCARDIUM; NITRIC OXIDE SYNTHASE TYPE III; PROTEIN KINASE C-EPSILON; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; RNA-BINDING PROTEINS; TRANSCRIPTION FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 67449088363     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.50.191     Document Type: Article

References (35)

1. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-26. (Review)
2. Yip HK, Hung WC, Yang CH, et al. Serum concentrations of high-sensitivity C-reactive protein predict progressively obstructive lesions rather than late restenosis in patients with unstable angina undergoing coronary artery stenting. Circ J 2005; 69: 1202-7.
3. Yip HK, Sun CK, Chang LT, Wu CJ. Strong correlation between serum levels of inflammatory mediators and their distribution in infarct-related coronary artery. Circ J 2006; 70: 838-45.
4. Schillinger M, Exner M, Amighi J, et al. Joint effects of C-reactive protein and glycated hemoglobin in predicting future cardiovascular events of patients with advanced atherosclerosis. Circulation 2003; 108: 2323-8.
5. Sander D, Schulze-Horn C, Bickel H, Gnahn H, Bartels E, Conrad B. Combined effects of hemoglobin A1c and C-reactive protein on the progression of subclinical carotid atherosclerosis: the INVADE study. Circulation 2006; 37: 351-7.
6. Selvin E, Marinopoulos S, Berkenblit G, et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 2004; 141: 421-31.
7. Milicevic Z, Raz I, Beattie SD, et al. Natural history of cardiovascular disease in patients with diabetes: role of hyperglycemia. Diabetes Care 2008; 31: S155-60. (Review)
8. Pradhan AD, Ridker PM. Do atherosclerosis and type 2 diabetes share a common inflammatory basis? Eur Heart J 2002; 23: 831-4. (Review)
9. Freeman DJ, Norrie J, Caslake MJ, et al. C-reactive protein is an independent predictor of risk for development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes 2002; 51: 1596-600.
10. Adler AI, Neil HA, Manley SE, Holman RR, Turner RC. Hyperglycemia and hyperinsulinemia at diagnosis of diabetes and their association with subsequent cardiovascular disease in the United Kingdom prospective diabetes study (UKPDS 47). Am Heart J 1999; 138: S353-9.
11. Laakso M. Glycemic control and the risk for coronary heart disease in patients with non-insulindependent diabetes mellitus. The Finish studies. Ann Intern Med 1996; 124: 127-30.
12. Khaw KT, Wareham N, Luben R, et al. Glycated hemoglobin, diabetes, and mortality in men in Norfolk cohort of European prospective investigation of cancer and nutrition (EPIC-Norfolk). BMJ 2001; 322: 15-8.
13. Domanski M, Krause-Steinrauf H, Deedwania P, et al. The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial. J Am Coll Cardiol 2003; 42: 914-22.
14. Eshaghian S, Horwich TB, Fonarow GC. An unexpected inverse relationship between HbA1c levels and mortality in patients with diabetes and advanced systolic heart failure. Am Heart J 2006; 151: 91.
15. Fang ZY, Prins JB, Marwick TH. Diabetes cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev 2004; 25: 543-67. (Review)
16. Poornima IG, Parikh P, Shannon RP. Diabetic cardiomyopathy: the search for a unifying hypothesis. Circ Res 2006; 98: 596-605. (Review)
17. Omland T, Lie RT, Aakvaag A, Aarsland T, Dickstein K. Plasma endothelin determinations as a prognostic indicator of 1-year mortality after acute myocardial infarction. Circulation 1994; 89: 1573-9.
18. Yip HK, Wu CJ, Chang HW, et al. Prognostic value of circulating levels of endothelin-1 in patients after acute myocardial infarction undergoing primary coronary angioplasty. Chest 2005; 127: 1491-7.
19. Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia-Gonzalez MJ, Kaski JC. High serum matrix metalloproteinase-9 level predicts increased risk of in-hospital cardiac events in patients with type 2 diabetes and ST segment elevation myocardial infarction. Atherosclerosis 2008; 196: 365-71.
20. Tao ZY, Cavasin MA, Yang F, Liu YH, Yang XP. Temporal changes in matrix metalloproteinase expression and inflammatory response associated with cardiac rupture after myocardial infarction in mice. Life Sci 2004; 74: 1561-72.
21. Tedgui A, Mallat Z. Anti-inflammatory mechanisms in the vascular wall. Circ Res 2001; 88: 877-87. (Review)
22. Garnier A, Fortin D, Deloménie C, Momken I, Veksler V, Ventura-Clapier R. Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles. J Physiol 2003; 551: 491-501.
23. Suwa M, Nakano H, Kumagai S. Effects of chronic AICAR treatment on fiber composition, enzyme activity, UCP3, and PGC-1 in rat muscles. J Appl Physiol 2003; 95: 960-8.
24. Vozzi C, Dupont E, Coppen SR, Yeh HI, Severs NJ. Chamber-related differences in connexin expression in the human heart. J Mol Cell Cardiol 1999; 31: 991-1003.
25. Kirchhoff S, Nelles E, Hagendorff A, Krüuger O, Traub O, Willecke K. Reduced cardiac conduction velocity and predisposition to arrhythmias in connexin40-deficient mice. Curr Biol 1998; 8: 299-302.
26. Lerner DL, Yamada KA, Schuessler RB, Saffitz JE. Accelerated onset and increased incidence of ventricular arrhythmias induced by ischemia in Cx43-deficient mice. Circulation 2000; 101: 547-52.
27. Peters NS, Green CR, Poole-Wilson PA, Severs NJ. Cardiac arrhythmogenesis and the gap junction. J Mol Cell Cardiol 1995; 27: 37-44. (Review)
28. Albert CJ, Ford DA. Protein kinase C translocation and PKC-dependent protein phosphorylation during myocardial ischemia. Am J Physiol 1999; 276: H642-50.
29. Baines CP, Pass JM, Ping P. Protein kinases and kinase-modulated effectors in the late phase of ischemic preconditioning. Basic Res Cardiol 2001; 96: 207-18. (Review)
30. Chang LT, Sun CK, Wang CY, et al. Downregulation of peroxisme proliferator activated receptor gamma co-activator 1 alpha in diabetic rats. Int Heart J 2006; 47: 901-10.
31. Oshima Y, Fujio Y, Nakanishi T, et al. STAT3 mediates cardioprotection against ischemia/reperfusion injury through metallothionein induction in the heart. Cardiovasc Res 2005; 65: 428-35.
32. Sheu JJ, Chang LT, Chiang CH, et al. Impact of diabetes on cardiomyocyte apoptosis and connexin43 gap junction integrity: role of pharmacological modulation. Int Heart J 2007; 48: 233-45.
33. Huss JM, Kelly DP. Mitochondrial energy metabolism in heart failure: a question of balance. J Clin Invest 2005; 115: 547-55. (Review)
34. Vondriska TM, Klein JB, Ping P. Use of functional proteomics to investigate PKC epsilon-mediated cardioprotection: the signaling module hypothesis. Am J Physiol Heart Circ Physiol 2001; 280: H1434-41. (Review)
35. Petersen CL, Munch M, Frandsen E, Nielsen JR, Hesse B, Dige-Petersen H. Serial changes in atrial natriuretic peptide and endothelin-1 concentrations. Their relationship to the cardiac performance of patients hospitalized for acute myocardial infarction. Cardiology 1998; 89: 210-5.